![]() HilleVax HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. | |||
Founding Date | Founding Date 2020 | Founding Date 2001 | Founding Date 2003 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Boston, US HQ | Locations Illkirch-Graffenstaden, FR HQ Montréal, CA | Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB |
Employees | Employees 31 | Employees 811% decrease | Employees 58 |
Financial | |||
Net income | Net income ($147.3m) (FY, 2024) | Net income N/A | Net income (£14.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 41.5m | Total funding raised $ 66.8m |

Domain Therapeutics is a biopharmaceutical company.
View company
e-therapeutics is a computational drug discovery company.
View company